Moolec Science (MLEC) Change in Intangibles (2023 - 2024)
Moolec Science's (MLEC) quarterly Change in Intangibles came in at -$284372.0 in Q4 2024, down 29.36% year-on-year from -$402568.2 in Q1 2024, and down 29.36% quarter-over-quarter from -$219829.0 in Q4 2023.
Moolec Science (MLEC) Change in Intangibles (2023 - 2024) Analysis & Trends
Moolec Science has disclosed Change in Intangibles across 2 years of filings, most recently posting -$284372.0 for Q4 2024.
- Change in Intangibles for Q4 2024 came in at -$284372.0, down 29.36% year-over-year; the trailing twelve-month figure through Dec 2024 was -$602159.0 (changed N/A YoY), and the FY2024 annual result was -$3.2 million, down 1867.19% from the prior year.
- Change in Intangibles came in at -$284372.0 for Q4 2024 at Moolec Science, down from -$219829.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of -$18184.0 in Q2 2023 to a low of -$284372.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -284,372.00 |
| Dec 31, 2024 | -284,372.00 |
| Dec 31, 2023 | -219,829.00 |
| Dec 31, 2023 | -219,829.00 |
| Jun 30, 2023 | -18,184.00 |
| Jun 30, 2023 | -18,184.00 |
| Mar 31, 2023 | -79,774.00 |
| Mar 31, 2023 | -79,774.00 |